肺癌中PD-L1表达与[18F]FAPI及[18F]FDG PET/CT摄取的关系
这项单中心回顾性研究连续纳入75例病理确诊的肺癌患者,均在2周内完成[18F]FAPI与[18F]FDG PET/CT检查。结果显示[18F]FAPI的TBRblood和TBRlung与PD-L1表达呈显著正相关,而[18F]FDG摄取与PD-L1表达无显著相关;TBRblood以7.76为界值可预测PD-L1表达水平。
要点
- [18F]FAPI PET/CT的TBRblood与PD-L1表达呈正相关(r=0.32,P<0.01)。
- 高PD-L1表达组[18F]FAPI平均TBRlung=36.16、TBRblood=10.75,高于低表达组的25.10和8.04。
- [18F]FDG摄取与PD-L1表达水平无显著相关。
核心结论
- 肺癌中[18F]FAPI摄取与PD-L1表达呈正相关。
- [18F]FAPI PET/CT联合PD-L1表达可能为评估肺癌免疫治疗反应提供更全面的方法。
研究设计与样本
- 单中心回顾性研究,连续纳入75例病理确诊的肺癌患者。
- 患者均在2周内完成[18F]FAPI与[18F]FDG PET/CT扫描,两次检查最短间隔20小时。
- PD-L1表达采用免疫组织化学评估并分为三组。
- PET/CT摄取参数包括活检肿瘤或纵隔转移淋巴结区域的SUVmax及正常组织(肺和血)的SUVmean,并计算肿瘤与本底的比值TBRlung和TBRblood。
主要发现
- [18F]FAPI PET/CT的TBRblood与PD-L1表达呈显著正相关(r=0.32,P<0.01)。
- [18F]FAPI PET/CT的TBRlung与PD-L1表达呈显著正相关(r=0.26,P<0.05)。
- 高PD-L1表达组[18F]FAPI平均TBRlung=36.16、平均TBRblood=10.75,低PD-L1表达组平均TBRlung=25.10、平均TBRblood=8.04。
- [18F]FDG摄取值与PD-L1表达水平之间未观察到统计学显著相关。
- 受试者工作特征分析显示[18F]FAPI PET/CT的TBRblood以7.76为界值可显著预测PD-L1表达水平(曲线下面积=0.68,P<0.01,灵敏度=75%,特异度=53.49%)。
关键数值与推荐
- [18F]FAPI PET/CT的TBRblood预测PD-L1表达水平的界值为7.76(曲线下面积=0.68,P<0.01,灵敏度=75%,特异度=53.49%)。
- PD-L1表达采用免疫组织化学评估并分为三组。
临床怎么用
- 原文结论认为[18F]FAPI PET/CT联合PD-L1表达可能为评估肺癌免疫治疗反应提供更全面的方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the correlation between [18F] labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography (PET)/computed tomography (CT) uptake and programmed death ligand 1 (PD-L1) expression in lung cancer and evaluate the predictive value of [18F]FAPI PET/CT for PD-L1 expression compared with [18F]fluorodeoxyglucose ([18F]FDG) PET/CT. METHODS: This single-center retrospective study consecutively enrolled patients with pathologically confirmed lung cancer who underwent [18F]FAPI and [18F]FDG PET/CT scans within 2 weeks, with a minimum interval of 20 h. PD-L1 expression was assessed using immunohistochemistry and stratified into three groups. PET/CT uptake parameters included the maximum standard uptake value (SUVmax) in the biopsy tumor or mediastinal metastasis lymph nodes area and the mean SUVs (SUVmean) of normal tissue (lung and blood). The ratios of SUVmax to the SUVmean for each normal tissue were denoted as the tumor-to-background ratios (TBRlung and TBRblood). All statistical analyses were conducted using IBM SPSS Statistics. Normality was assessed, and for non-normally distributed data, the Kruskal-Wallis and Mann-Whitney U tests were applied. Associations between variables were evaluated using Spearman's rank correlation. All tests were two-sided, with a P-value < 0.05 considered statistically significant. RESULTS: Among the 75 cases included on the final analysis, the TBRblood and TBRlung derived from [18F]FAPI PET/CT were significantly positively correlated with PD-L1 expression (r = 0.32, P < 0.01; r = 0.26, P < 0.05). Additionally, cases with high PD-L1 expression showed significantly higher [18F]FAPI uptake values (mean TBRlung=36.16; mean TBRblood=10.75) compared with those with low PD-L1 expression (mean TBRlung=25.10; mean TBRblood=8.04). No statistically significant correlation was observed between [18F]FDG uptake values and PD-L1 expression level. Receiver operating characteristic analysis identified TBRblood on [18F]FAPI PET/CT with a cutoff value of 7.76 (area under the curve = 0.68, P < 0.01, sensitivity = 75%, and specificity = 53.49%) as a significant predictor of the level of PD-L1 expression. CONCLUSION: [18F]FAPI uptake was positively correlated with PD-L1 expression in lung cancer. The combination of [18F]FAPI PET/CT and PD-L1 expression may offer a more comprehensive approach to assessing the response of lung cancer to immunotherapy. TRIAL REGISTRATION: This study was approved by the Clinical Research Ethics Committee of our institution (institutional review board approval no. SDZLEC2021-112-02).
引用
- Qin J, Han C, Li H, et al. Relationship between PD-L1 expression and [18F]FAPI versus [18F]FDG uptake on PET/CT in lung cancer. Eur J Nucl Med Mol Imaging. 2025. PMID: 40113644. doi:10.1007/s00259-025-07201-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。